Dewpoint Therapeutics GmbH
 | |
| Industry sector: | Biotechnology |
| Products, services: | Condensate drug discovery and development |
| Locations: | Frankfurt, Dresden, Boston |
| Date of foundation: | 2018 |
| Number of employees: | 150 |
| The company: | Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has programs across an ambitious pipeline spanning oncology, neurodegenerative, cardiopulmonary and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck and Pfizer. Dewpoint scientists work to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. |
| Planned staff requirements: | 20 |
| Area of expertise: | Biochemistry, biological sciences, biotechnology, chemistry, informatics |
| Additional area of expertise: | Bioinformatics |
| Desired qualifications: | PostDoc, PhD, master, students |
| Desired skills of applicants: | Ability to communicate effectively in English, the shared language of our multicultural team |
| Career opportunities: | Direct entry & Internships |
| Trainee program (positions/year): | Yes (2) |
| Contact: | https://dewpointx.com/join-us/ |
